Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide. LiSyM-EMI looks into the transition from steatosis to non-alcoholic steatohepatitis (NASH) as the disease-defining moment in NAFLD. A systems analysis of these early disease events will be performed to elucidate the molecular mechanisms that trigger disease establishment.
Authors: Josch Pauling, E. Klipp
Date Published: 22nd Dec 2016
Journal: J Integr Bioinform
PubMed ID: 28187425
Citation: J Integr Bioinform. 2016 Dec 22;13(1):299. doi: 10.2390/biecoll-jib-2016-299.
Authors: V. Schutzhold, J. Hahn, K. Tummler, E. Klipp
Date Published: 27th Sep 2016
Journal: Front Mol Biosci
PubMed ID: 27730126
Citation: Front Mol Biosci. 2016 Sep 27;3:57. doi: 10.3389/fmolb.2016.00057. eCollection 2016.